Invesco Ltd. Homology Medicines, Inc. Transaction History

Invesco Ltd.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.39 - $3.12 $21,924 - $49,211	-15,773 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.6 - $4.17 $42,276 - $67,804	-16,260 Reduced 50.76%	15,773 $48,000
Q4 2021 Feb 14, 2022	SELL	$3.64 - $7.78 $23,012 - $49,185	-6,322 Reduced 16.48%	32,033 $116,000
Q3 2021 Nov 15, 2021	BUY	$6.01 - $8.71 $13,618 - $19,736	2,266 Added 6.28%	38,355 $302,000
Q2 2021 Aug 17, 2021	BUY	$6.02 - $9.64 $70,126 - $112,296	11,649 Added 47.66%	36,089 $262,000

Q1 2021 May 17, 2021	BUY	$9.17 - $14.8 $224,114 - $361,712	24,440 New	24,440 $230,000
Q2 2020 Aug 14, 2020	SELL	$12.07 - $19.34 $420,820 - $674,289	-34,865 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$12.5 - $22.04 $435,812 - $768,424	34,865 New	34,865 $542,000
Q1 2019 May 15, 2019	SELL	$19.76 - $29.57 $795,399 - $1.19 Million	-40,253 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$18.39 - $26.3 $740,252 - $1.06 Million	40,253 New	40,253 $900,000

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.